Antihypertensive Agents and Incident Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Observational Studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2426-0266
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antihypertensive Agents and Incident Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Observational Studies ; volume:9 ; number:4 ; day:28 ; month:9 ; year:2022 ; pages:715-724 ; date:10.2022
The journal of prevention of Alzheimer's disease ; 9, Heft 4 (28.9.2022), 715-724, 10.2022
- Creator
-
Adesuyan, M.
Jani, Y. H.
Alsugeir, D.
Cheung, E. C. L.
Chui, C. S. L.
Howard, R.
Wong, I. C. K.
Brauer, Ruth
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2022.77
- URN
-
urn:nbn:de:101:1-2023010709062454494300
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Adesuyan, M.
- Jani, Y. H.
- Alsugeir, D.
- Cheung, E. C. L.
- Chui, C. S. L.
- Howard, R.
- Wong, I. C. K.
- Brauer, Ruth
- SpringerLink (Online service)
Other Objects (12)
Antihypertensive agents
Cognitive Performance and Incident Alzheimer’s Dementia in Men Versus Women
Repurposed agents in the Alzheimer’s disease drug development pipeline
Incident stroke in patients with Alzheimer’s disease: systematic review and meta-analysis
Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents
Bis-γ-carbolines as new potential multitarget agents for Alzheimer’s disease
Development of selective fluorescent imaging agents for neurofibrillary tangles in Alzheimer’s diagnosis
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives
Antihypertensive agents
Cognitive Performance and Incident Alzheimer’s Dementia in Men Versus Women
Repurposed agents in the Alzheimer’s disease drug development pipeline
Incident stroke in patients with Alzheimer’s disease: systematic review and meta-analysis
Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents
Bis-γ-carbolines as new potential multitarget agents for Alzheimer’s disease
Development of selective fluorescent imaging agents for neurofibrillary tangles in Alzheimer’s diagnosis
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives
Antihypertensive agents
Cognitive Performance and Incident Alzheimer’s Dementia in Men Versus Women
Repurposed agents in the Alzheimer’s disease drug development pipeline
Incident stroke in patients with Alzheimer’s disease: systematic review and meta-analysis
Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents
Bis-γ-carbolines as new potential multitarget agents for Alzheimer’s disease
Development of selective fluorescent imaging agents for neurofibrillary tangles in Alzheimer’s diagnosis
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action